BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19055942)

  • 21. Targeting of FAK Ser910 by ERK5 and PP1delta in non-stimulated and phorbol ester-stimulated cells.
    Villa-Moruzzi E
    Biochem J; 2007 Nov; 408(1):7-18. PubMed ID: 17692050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
    Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
    Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of focal adhesion kinase in non-small cell lung cancer.
    Carelli S; Zadra G; Vaira V; Falleni M; Bottiglieri L; Nosotti M; Di Giulio AM; Gorio A; Bosari S
    Lung Cancer; 2006 Sep; 53(3):263-71. PubMed ID: 16842883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
    Hu XW; Meng D; Fang J
    Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of focal adhesion kinase correlates with cellular proliferation and apoptosis during 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis.
    Xia J; Lv N; Hong Y; Li C; Tao X; Chen X; Cheng B
    J Oral Pathol Med; 2009 Jul; 38(6):524-9. PubMed ID: 19141060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
    Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
    J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
    Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells.
    Earley S; Plopper GE
    Biochem Biophys Res Commun; 2006 Nov; 350(2):405-12. PubMed ID: 17010315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK).
    Sun T; Zhao N; Ni CS; Zhao XL; Zhang WZ; Su X; Zhang DF; Gu Q; Sun BC
    Cancer Lett; 2009 Nov; 285(2):141-50. PubMed ID: 19482420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor.
    Andersson S; D'Arcy P; Larsson O; Sehat B
    Biochem Biophys Res Commun; 2009 Sep; 387(1):36-41. PubMed ID: 19545541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer.
    Schultze A; Fiedler W
    Expert Opin Investig Drugs; 2010 Jun; 19(6):777-88. PubMed ID: 20465362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells.
    Zang XP; Pento JT; Tari AM
    Anticancer Res; 2008; 28(1A):133-7. PubMed ID: 18383836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity.
    Theocharis SE; Klijanienko JT; Padoy E; Athanassiou S; Sastre-Garau XX
    Med Sci Monit; 2009 Aug; 15(8):BR221-6. PubMed ID: 19644410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells.
    Quach NL; Rando TA
    Dev Biol; 2006 May; 293(1):38-52. PubMed ID: 16533505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility.
    Papusheva E; Mello de Queiroz F; Dalous J; Han Y; Esposito A; Jares-Erijmanxa EA; Jovin TM; Bunt G
    J Cell Sci; 2009 Mar; 122(Pt 5):656-66. PubMed ID: 19208768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell.
    Kim SH; Kim SH
    Cell Biochem Funct; 2008; 26(5):539-47. PubMed ID: 18543351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention.
    Parsons JT; Slack-Davis J; Tilghman R; Roberts WG
    Clin Cancer Res; 2008 Feb; 14(3):627-32. PubMed ID: 18245520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 8 and cell migration to inflammatory sites: the regulation of focal adhesion kinase under conditions of migratory desensitization.
    Cohen-Hillel E; Yron I; Meshel T; Ben-Baruch A
    Isr Med Assoc J; 2007 Aug; 9(8):579-83. PubMed ID: 17877062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.